Probucol as a potent inhibitor of oxygen radical-induced lipid peroxidation and DNA damage: in vitro studies

REFERENCES

• Tappel AL. Lipid peroxidation damage to cell components. Fed Proc 1973; 32: 1870–1874.
   PubMedGoogle Scholar
• Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527–605.
   PubMed Web of Science ®Google Scholar
• Sies, H. Biochemistry of oxidative stress. Angew Chem Int Engl 1986; 25: 1058–1071.
   Web of Science ®Google Scholar
• Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49: 481–493.
   PubMed Web of Science ®Google Scholar
• Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 1302–1309.
   PubMed Web of Science ®Google Scholar
• Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M. Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 1989; 264: 20509–20512.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1–85.
   PubMed Web of Science ®Google Scholar
• Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parental administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663–673.
   PubMed Web of Science ®Google Scholar
• Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by ferric nitrilotriacetate. Jpn Arch Intern Med 1982; 29: 485–491.
   Google Scholar
• Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 1996; 46: 311–332.
   PubMed Web of Science ®Google Scholar
• Hiroyasu M, Ozeki M, Kohda H, Echizenya M, Tanaka T, Hiai H, Toyokuni S. Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 2002; 160: 419–424.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Gin i U, Athar M. Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 1995; 212: 557–563.
   PubMed Web of Science ®Google Scholar
• Athar M, Iqbal M. Ferric nitrilotriacetate promotes N-diethyl nitrosoamine-induced renal tumorigenesis in rat: implications for the involvement of oxidative stress. Carcinogenesis 1998; 19: 1133–1139.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Sharma SD, Rahman A, Trikha P, Athar M. Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis. Cancer Lett 1999; 141: 151–157.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Gin i U, Gin i DK, Athar M. Evidence that Fe-NTA induced renal prostaglandin F2a is responsible for hyperplastic response in kidney: implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion. Biochem Mol Biol Int 1997; 42: 1115–1124.
   PubMedGoogle Scholar
• Iqbal M, Gin i U, Gin i DK, Alam MS, Athar M. Age dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parental administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of FINE-protein adducts in oxidative stress and carcinogenesis. Arch Biochem Biophys 1999; 365: 101–112.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Sharma SD, Mizote A, Fujisawa M, Okada S. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate-mediated DNA damage: implications for carcinogenesis. Teratog Carcinog Mutagen 2003; 1: 13–21.
   PubMedGoogle Scholar
• Hartwig A, Klyszez-Nasko H, Schlepegrell R, Beyersmann D. Cellular damage by ferric nitrilotriacetate and ferric citrate in V79 cells: interrelationship between lipid peroxidation, DNA strand breaks and sister chromatid exchanges. Carcinogenesis 1993; 14: 107–112.
   PubMed Web of Science ®Google Scholar
• Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997; 57: 2410–2414.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Rezazadeh H, Ansar S, Athar M. a-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress. Hum Exp Toxicol 1998; 17: 163–171.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Athar M. Attenuation of iron-nitrilotriacetate mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Food Chem Toxicol 1998; 36: 485–495.
   PubMed Web of Science ®Google Scholar
• Ansar S, Iqbal M, Athar M. Nordihydroguaretic acid is a potent inhibitor of ferric nitrilotriacetate mediated hepatic and renal toxicity and renal tumor promotion in mice. Carcinogenesis 1999; 20: 599–606.
   PubMed Web of Science ®Google Scholar
• Kimoto T, Koya S, Hino K et al. Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and Artepillin C. Pat hol Int 2000; 50: 679–689.
   PubMed Web of Science ®Google Scholar
• Matos HR, Capelozzi VL, Gomes OF, Mascio PD, Medeiros MH. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate. Arch Biochem Biophys 2001; 396: 171–177.
   PubMed Web of Science ®Google Scholar
• Iqbal M, Okazaki Y, Okada S. In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (1-1202)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen 2003; 1: 151–160.
   PubMedGoogle Scholar
• Zimetbaum P, Eder H, Frishman W. Probucol: pharmacology and clinical application. J Clin Pharmacol 1990; 30: 3–9.
   PubMed Web of Science ®Google Scholar
• Kuzuya M, Kuzuya F. Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 1993; 14: 67–77.
   PubMed Web of Science ®Google Scholar
• Bridges AB, Scott NA, Belch JJ. Probucol, a superoxide free radical scavenger in vitro. Atherosclerosis 1991; 89: 263–265.
   PubMed Web of Science ®Google Scholar
• Hiramatsu M, Liu J, Edamatsu R, Ohba S, Kadowaki D, Mori A. Probucol scavenged 1,1-dipheny1-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances. Free Radic Biol Med 1994; 16: 201–206.
   PubMed Web of Science ®Google Scholar
• Dage RC, Anderson BA, Mao SJ, Koerner JE. Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovasc Pharmacol 1991; 17: 158–165.
   PubMedGoogle Scholar
• Bird JE, Milhoan K, Wilson CB et al. Ischemic acute renal failure and antioxidant therapy in rat. The relation between glomerular and tubular dysfunction. J Clin Invest 1988; 81: 1630–1638.
   PubMed Web of Science ®Google Scholar
• Siveski-Iliskovic N, Hill M, Chow DA, Singal PK. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995; 91: 10–15.
   PubMed Web of Science ®Google Scholar
• Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low-density lipoprotein. Use of a new water-soluble probucol derivative. J Clin Invest 1992; 89: 1618–1621.
   PubMed Web of Science ®Google Scholar
• Wright JR, Colby HD, Miles PR. Cytosolic factors, which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 1981; 206: 296–304.
   PubMed Web of Science ®Google Scholar
• Athar M, Iqbal M, Beg MU, Al-Ajmi D, Al-Muzaini S. Airborne dust collected from Kuwait in 1991-1992 augments peroxidation of cellular membrane lipids and enhances DNA damage. Environ Int 1998; 24: 205–212.
   Web of Science ®Google Scholar
• Toyokuni S, Uchida K, Okamato K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 2616–2620.
   PubMed Web of Science ®Google Scholar
• Haklar G, Sirikci 0, Ozer NK, Yalcin AS. Measurement of reactive oxygen species by chemiluminescence in diet-induced atherosclerosis: protective roles of vitamin E and probucol on different radical species. Int J Clin Lab Res 1998; 28: 122–126.
   PubMedGoogle Scholar
• Ito M, Suzuki Y, Ishibara M, Suzuki Y. Anti-ulcer effects of antioxidants: effect of probucol. Eur J Pharmacol 1998; 354: 189–196.
   PubMed Web of Science ®Google Scholar
• Gotoh N, Shimizu K, Komuro E, Tsuchiya J, Noguchi N, Nikki E. Antioxidant activities of probucol against lipid peroxidations. Biochim Biophys Acta 1992; 1128: 147–154.
   PubMed Web of Science ®Google Scholar
• Qin X, Zhang S, Zarkovic M et al. Inhibitory effect of probucol on nephrotoxicity induced by ferric nitrilotriacetate (Fe-NTA) in rats. Carcinogenesis 1995; 16: 2549–2552.
   PubMed Web of Science ®Google Scholar
• Zarkovic M, Qin X, Nakatsuru Y et al. Inhibitory effect of probucol on benzo[a]pyrene induced lung tumorigenesis. Carcinogenesis 1995; 16: 2599–2601.
   PubMed Web of Science ®Google Scholar
• Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Jpn J Cancer Res 1999; 90: 1224–1230.
   PubMedGoogle Scholar
• El-Demerdash E, El-Denshary E, El-Didi M, Al-Gharabli N, Osman AM. Probucol and liver efficiency during chemically-induced hepatocarcinogenesis. Anticancer Res 2002; 22: 977–984.
   PubMed Web of Science ®Google Scholar
• Iliskovic N, Hasinoff BB, Malisza KL, Danelisen I, Singal PK. Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Mol Cell Biochem 1999; 196: 43–49.
   PubMed Web of Science ®Google Scholar